Intermediaries Gain From Rising Insulin Prices in the US Intermediaries Gain From Rising Insulin Prices in the US

USC economists report that insulin manufacturers are receiving an increasingly smaller share of expenditures; instead the middlemen are getting a bigger cut.Medscape Medical News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news